How should a patient with a solitary hard lymph node in the right inguinal (groin) region, associated with lower leg eczema, and laboratory results showing mildly elevated alkaline phosphatase (all phos) and thrombocytosis (elevated platelet count), be investigated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a patient with an isolated hard right inguinal node present for 3 weeks, associated lower leg eczema, and marginally elevated alkaline phosphatase and platelet count, I recommend a comprehensive evaluation starting with a complete history and physical examination, followed by an ultrasound of the inguinal node and potentially an excisional biopsy if the node is suspicious. The patient's presentation with a hard inguinal node and associated eczema suggests the possibility of reactive lymphadenopathy, but the persistence of the node and the elevated laboratory values necessitate further investigation to rule out malignancy or infection. Key steps in the evaluation include:

  • Complete blood count, comprehensive metabolic panel, LDH, and inflammatory markers (ESR, CRP) to assess for signs of infection, inflammation, or malignancy 1
  • Ultrasound of the inguinal node to assess its characteristics, such as size, shape, and echotexture, which can help guide the decision for further diagnostic procedures like fine-needle aspiration or excisional biopsy 1
  • Consideration of a CT scan of the abdomen and pelvis to evaluate for additional lymphadenopathy or other signs of systemic disease
  • Treatment of the lower leg eczema with topical corticosteroids and moisturizers, as this may be contributing to the reactive lymphadenopathy
  • Close follow-up in 2-4 weeks to reassess the node's response to treatment and determine if further diagnostic or therapeutic interventions are needed. Given the potential for malignancy, such as lymphoma, it is crucial to approach this patient with a high index of suspicion and to not hesitate to proceed with more invasive diagnostic tests if initial evaluations are inconclusive or if the patient's condition does not improve with initial management. The most recent and highest quality evidence supports a thorough and systematic approach to evaluating lymphadenopathy, considering both benign and malignant causes, and tailoring the diagnostic workup based on the patient's specific presentation and risk factors 1.

From the Research

Patient Presentation

The patient presents with an isolated hard node in the right inguinal region, accompanied by lower leg eczema. The node has been present for 3 weeks, and there are no other symptoms. Blood tests indicate a marginally elevated alkaline phosphatase (all phos) and platelet count.

Investigation and Management

To investigate the patient's condition, consider the following steps:

  • Perform a thorough physical examination, including an abdominal examination, to identify any potential underlying causes of the node and eczema 2.
  • Interpret liver function tests, including alkaline phosphatase, in the context of the patient's overall clinical presentation 3, 4, 5.
  • Consider the possibility of liver disease, despite the absence of other symptoms, and evaluate the patient's liver function tests in conjunction with other biochemical parameters, such as albumin, INR, and platelet count 4.
  • Categorize abnormal liver biochemical tests based on the pattern and magnitude of aminotransferase elevation to guide further investigation and management 5.

Potential Causes and Further Evaluation

Potential causes of the patient's presentation include:

  • Hepatocellular or cholestatic pattern liver disease 5.
  • Other conditions, such as biliary pathology, autoimmune disorders, or medication-induced liver injury 5.
  • Chronic pain or biopsychosocial factors, although these may be less relevant in this case 6. Further evaluation may involve additional laboratory tests, imaging studies, or specialist referral to determine the underlying cause of the patient's condition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Liver function tests: their role in the diagnosis of hepatobiliary diseases.

Journal of infusion nursing : the official publication of the Infusion Nurses Society, 2005

Research

Liver tests.

Casopis lekaru ceskych, 2022

Research

Abnormal liver enzymes: A review for clinicians.

World journal of hepatology, 2021

Research

Practical management strategies for the chronic pain patient.

The Journal of family practice, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.